Northeast Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.74M | Buy |
4,802
+19
| +0.4% | +$6.5K | 0.06% | 96 |
|
|
2026
Q1 | $1.68M | Buy |
4,783
+362
| +8% | +$129K | 0.07% | 92 |
|
|
2025
Q4 | $1.45M | Sell |
4,421
-30
| -0.7% | -$9.52K | 0.06% | 99 |
|
|
2025
Q3 | $1.26M | Sell |
4,451
-534
| -11% | -$155K | 0.05% | 100 |
|
|
2025
Q2 | $1.39M | Hold |
4,985
| – | – | 0.06% | 98 |
|
|
2025
Q1 | $1.55M | Sell |
4,985
-154
| -3% | -$45.5K | 0.07% | 89 |
|
|
2024
Q4 | $1.34M | Hold |
5,139
| – | – | 0.06% | 96 |
|
|
2024
Q3 | $1.66M | Sell |
5,139
-130
| -2% | -$42.5K | 0.07% | 91 |
|
|
2024
Q2 | $1.65M | Sell |
5,269
-155
| -3% | -$45.5K | 0.08% | 91 |
|
|
2024
Q1 | $1.54M | Sell |
5,424
-58
| -1% | -$17K | 0.08% | 90 |
|
|
2023
Q4 | $1.58M | Sell |
5,482
-200
| -4% | -$54.5K | 0.08% | 91 |
|
|
2023
Q3 | $1.53M | Buy |
5,682
+250
| +5% | +$62.4K | 0.09% | 89 |
|
|
2023
Q2 | $1.21M | Sell |
5,432
-749
| -12% | -$174K | 0.07% | 93 |
|
|
2023
Q1 | $1.49M | Sell |
6,181
-207
| -3% | -$50.8K | 0.09% | 87 |
|
|
2022
Q4 | $1.68M | Hold |
6,388
| – | – | 0.11% | 87 |
|
|
2022
Q3 | $1.44M | Sell |
6,388
-50
| -0.8% | -$12.1K | 0.1% | 86 |
|
|
2022
Q2 | $1.57M | Buy |
6,438
+48
| +0.8% | +$11.8K | 0.1% | 88 |
|
|
2022
Q1 | $1.54M | Sell |
6,390
-64
| -1% | -$14.7K | 0.08% | 95 |
|
|
2021
Q4 | $1.45M | Sell |
6,454
-125
| -2% | -$26.4K | 0.07% | 97 |
|
|
2021
Q3 | $1.4M | Sell |
6,579
-382
| -5% | -$87.9K | 0.07% | 101 |
|
|
2021
Q2 | $1.7M | Hold |
6,961
| – | – | 0.09% | 96 |
|
|
2021
Q1 | $1.73M | Sell |
6,961
-14
| -0.2% | -$3.34K | 0.1% | 93 |
|
|
2020
Q4 | $1.6M | Hold |
6,975
| – | – | 0.1% | 94 |
|
|
2020
Q3 | $1.77M | Buy |
6,975
+382
| +6% | +$94.6K | 0.12% | 82 |
|
|
2020
Q2 | $1.55M | Hold |
6,593
| – | – | 0.12% | 80 |
|
|
2020
Q1 | $1.34M | Buy |
6,593
+24
| +0.4% | +$5.24K | 0.12% | 83 |
|
|
2019
Q4 | $1.58M | Sell |
6,569
-133
| -2% | -$29.3K | 0.12% | 87 |
|
|
2019
Q3 | $1.3M | Hold |
6,702
| – | – | 0.1% | 94 |
|
|
2019
Q2 | $1.24M | Buy |
6,702
+2,716
| +68% | +$486K | 0.1% | 96 |
|
|
2019
Q1 | $757K | Sell |
3,986
-2
| -0.1% | -$382 | 0.06% | 101 |
|
|
2018
Q4 | $776K | Buy |
3,988
+433
| +12% | +$84.5K | 0.07% | 100 |
|
|
2018
Q3 | $737K | Sell |
3,555
-82
| -2% | -$16.2K | 0.06% | 106 |
|
|
2018
Q2 | $671K | Buy |
3,637
+2
| +0.1% | +$354 | 0.06% | 108 |
|
|
2018
Q1 | $620K | Hold |
3,635
| – | – | 0.05% | 106 |
|
|
2017
Q4 | $632K | Hold |
3,635
| – | – | 0.05% | 109 |
|
|
2017
Q3 | $678K | Buy |
3,635
+900
| +33% | +$159K | 0.06% | 105 |
|
|
2017
Q2 | $471K | Sell |
2,735
-72
| -3% | -$11.7K | 0.04% | 118 |
|
|
2017
Q1 | $461K | Hold |
2,807
| – | – | 0.04% | 119 |
|
|
2016
Q4 | $410K | Sell |
2,807
-230
| -8% | -$34.6K | 0.04% | 123 |
|
|
2016
Q3 | $507K | Buy |
3,037
+1,067
| +54% | +$180K | 0.05% | 114 |
|
|
2016
Q2 | $300K | Hold |
1,970
| – | – | 0.03% | 130 |
|
|
2016
Q1 | $295K | Buy |
1,970
+600
| +44% | +$89.1K | 0.03% | 129 |
|
|
2015
Q4 | $222K | Buy |
+1,370
| New | +$215K | 0.02% | 145 |
|
|
2015
Q3 | – | Sell |
-1,320
| Closed | -$203K | – | 158 |
|
|
2015
Q2 | $203K | Buy |
+1,320
| New | +$211K | 0.02% | 153 |
|
Other funds holding AMGN
Northeast Investment Management's AMGN Position: Q2 2026 in Review
Northeast Investment Management increased its Amgen (AMGN) stake by 0.4% in Q2 2026, buying an estimated $6.5K and bringing the position to 4,802 shares worth $1.74M. The position accounts for 0.06% of the portfolio, ranked #96.
Northeast Investment Management first reported a position in AMGN in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.77M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Northeast Investment Management held 4,802 shares of Amgen worth $1.74M as of Q2 2026.
- Northeast Investment Management bought 19 Amgen shares in Q2 2026, an estimated $6.5K.
- Amgen made up 0.06% of Northeast Investment Management's portfolio in Q2 2026, its #96 holding.
- Northeast Investment Management first reported a position in Amgen in Q2 2015 and has held it in 44 quarters since.
- Northeast Investment Management's Amgen position peaked at $1.77M in Q3 2020.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.